Investing.com - Adverum Biotechn (NASDAQ: ADVM) reported third quarter EPS of $-0.330, $0.01 worse than the analyst estimate of $-0.320. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
Adverum Biotechn's stock price closed at $0.910. It is down -51.850% in the last 3 months and up 18.940% in the last 12 months.
Adverum Biotechn saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Adverum Biotechn's stock price’s past reactions to earnings here.
According to InvestingPro, Adverum Biotechn's Financial Health score is "fair performance".
Check out Adverum Biotechn's recent earnings performance, and Adverum Biotechn's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar